Epstein-Barr virus-related lymphoproliferative disorders in T-cell repleted haploidentical transplantation with post-transplant cyclophosphamide
dc.authorid | uygun, vedat/0000-0003-3257-7798 | |
dc.authorscopusid | 10043117000 | |
dc.authorscopusid | 26323267700 | |
dc.authorscopusid | 6504521157 | |
dc.authorscopusid | 57194743058 | |
dc.authorscopusid | 57214444713 | |
dc.authorscopusid | 27267680800 | |
dc.authorscopusid | 8327807300 | |
dc.authorwosid | Yalcin, Koray/AGD-9441-2022 | |
dc.authorwosid | uygun, vedat/AGH-4534-2022 | |
dc.contributor.author | Uygun, Vedat | |
dc.contributor.author | Ozsan, Nazan | |
dc.contributor.author | Daloglu, Hayriye | |
dc.contributor.author | Ozturkmen, Seda | |
dc.contributor.author | Yalcin, Koray | |
dc.contributor.author | Karasu, Gulsun | |
dc.contributor.author | Yesilipek, Akif | |
dc.date.accessioned | 2023-01-12T19:51:29Z | |
dc.date.available | 2023-01-12T19:51:29Z | |
dc.date.issued | 2022 | |
dc.department | N/A/Department | en_US |
dc.description.abstract | EBV-associated lymphoproliferative disorders (LPDs) are common in hematopoietic stem cell transplantation (HSCT) with T-cell-depleted grafts, but are extremely rare in HSCT patients with T-cell-replete grafts with post-transplant cyclophosphamide (PTCy). Here we present the cases of two pediatric patients who developed EBV-related LPD after T-cell-replete haplo-HSCT with PTCy. One of these is the first reported case of EBV-positive mucocutaneous ulcer (EBVMCU) developing after PTCy. EBV-related diseases are rare in T-cell-replete haplo-HSCT patients with PTCy. However, in patients with risk factors, it is reasonable to screen for EBV viremia for LPD. | en_US |
dc.identifier.doi | 10.1007/s12185-021-03267-8 | |
dc.identifier.endpage | 604 | en_US |
dc.identifier.issn | 0925-5710 | |
dc.identifier.issn | 1865-3774 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 34826107 | en_US |
dc.identifier.scopus | 2-s2.0-85119955552 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 600 | en_US |
dc.identifier.uri | https://doi.org/10.1007/s12185-021-03267-8 | |
dc.identifier.uri | https://hdl.handle.net/11454/76283 | |
dc.identifier.volume | 115 | en_US |
dc.identifier.wos | WOS:000722865400001 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer Japan Kk | en_US |
dc.relation.ispartof | International Journal of Hematology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Post-transplant cyclophosphamide | en_US |
dc.subject | Lymphoproliferative disorder | en_US |
dc.subject | EBV-positive mucocutaneous ulcer | en_US |
dc.subject | Epstein-Barr virus | en_US |
dc.subject | Management | en_US |
dc.subject | Blood | en_US |
dc.title | Epstein-Barr virus-related lymphoproliferative disorders in T-cell repleted haploidentical transplantation with post-transplant cyclophosphamide | en_US |
dc.type | Article | en_US |